GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (STU:OVXA) » Definitions » Other Income (Expense)

Ovoca Bio (STU:OVXA) Other Income (Expense) : €-3.23 Mil (TTM As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Ovoca Bio Other Income (Expense)?

Ovoca Bio's other income expense for the Ovoca Bio's pretax income for the six months ended in Jun. 2024 was €0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-3.23 Mil.

Ovoca Bio Other Income (Expense) Historical Data

The historical data trend for Ovoca Bio's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio Other Income (Expense) Chart

Ovoca Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 -0.10 0.87 -0.15 -3.23

Ovoca Bio Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.15 - -3.23 -

Ovoca Bio Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ovoca Bio  (STU:OVXA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Ovoca Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (STU:OVXA) » Definitions » Other Income (Expense)
Comparable Companies
VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170 OCSE:GMAB MRNA INCY SHSE:603392
Traded in Other Exchanges
OVXA:Ireland OVB.GB:UK OVB:UK
Address
17 Pembroke Street Upper, Dublin, IRL, D02 AT22
Website
https://www.ovocabio.com
Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio Headlines

No Headlines